Management of Intracranial Pressure in Traumatic Brain Injury by Ordookhanian, Christ et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Management of Intracranial Pressure in Traumatic
Brain Injury
Christ Ordookhanian, Meena Nagappan,
Dina Elias and Paul E. Kaloostian
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/intechopen.72829
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, 
and reproduction in any medium, provided the original work is properly cited. 
Christ Ordookhanian, Meena Nagappan, Dina Elias 
and Paul E. Kaloostian
Additional information is available at the end of the chapter
Abstract
Traumatic brain injury (TBI) is the result of an external force acting upon the head, 
causing damage to the brain. The severity of injury, mechanism by which the injury 
occurs, and the frequency of the high-force impact all play a role in the determination 
of a TBI. TBI describes a wide range of traumatic pathologies which is comprised of 
damage done to a multitude of cranial central nervous system components. TBI patients 
typically present with a series of symptoms are correlated with the presence of an intra-
cranial injury, such as physical/cognitive difficulties. A major concern associated with 
intracranial injuries is the management of intracranial pressure (ICP), a resulting fac-
tor of a TBI which facilitates into intracranial hematoma and/or cerebral edema. These 
conditions have adverse effects on one’s brain, and the immediate management and 
relief of intracranial pressure are crucial in avoiding hydrocephalus and brain hernia-
tion, conditions which lead to sensory loss and even death. In this chapter, we will begin 
by thoroughly understanding what a TBI is, its clinical presentation, and the first-tier 
examination to determine severity. Then, we will progress into the anatomy of the brain, 
followed by a thorough investigation into intracranial pressure management strategies 
and prognosis.
Keywords: intracranial, ICP, trauma, head injury, brain herniation, cerebral edema, 
hydrocephalus, shunt, skull, blood, cerebral fluid, pressure, relief
1. Introduction
The onset of increased intracranial pressure is often attributed to many pathologies such as 
large artery acute ischemic stroke, intracranial neoplasms, or disorders such as meningitis. 
The most common reason for which the onset of intracranial pressure is observed is due to 
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traumatic brain injuries, such as colliding one’s head into a hard object as a result of an acci-
dent. By definition, an intracranial pressure that exceeds 20 mm Hg is considered high and 
indicative for the need of immediate treatment [1]. Through the advancement of medicine 
and technology, the variety of treatment options available to relieve patients of increased 
intracranial pressure has grown tremendously. In practice today, there exists a multitude 
of treatment options ranging from nonsurgical interventions to surgical interventions [2, 3]. 
In this chapter, we will discuss the primary pathology of patients presenting with increased 
intracranial pressure (ICP) as a result of traumatic brain injuries (TBIs), and we will take a 
generalized perspective on this pathology by discussing a multitude of topics we find crucial 
to your understanding of the management of ICP in TBI patients.
2. Intracranial pressure management of traumatic brain injury
2.1. The occurrence of traumatic brain injury
Traumatic brain injury (TBI) is composed of an external mechanical force, whether it be a 
change in acceleration or impact by projectile that causes a temporary or at times a perma-
nent brain function impairment as well as physical damage to the human brain anatomy. It 
is important that we establish a clear understanding of the term TBI and its partnering term 
non-TBI. A traumatic brain injury is brought on by the impact generated by an external force, 
while a nontraumatic brain injury is brought on by internal forces such as a stroke or infec-
tion. A traumatic brain injury, which we have now learned arises from external forces, can 
come in two pathological forms: penetrating and nonpenetrating. This classification presents 
as simply as it is defined. A penetrating TBI results in several lesions starting from one’s head 
down to the cerebral level, and these often occur in severe accidents or injuries. A clear and 
prime example of a penetrating TBI is one that occurs all too often to members of our mili-
tary, a foreign projectile being discharged from an external high-force machine, which then 
strikes a human head [4]. A nonpenetrating TBI is the form that we will cover more in depth 
within this chapter and results from an external force acting upon the head, but it does not 
penetrate any layer of human anatomy. Within the clinic, the formal classification of TBIs may 
be reduced to open-head injury for patients presenting with traumatic brain injuries of the 
penetrating type, and for patients presenting with a traumatic brain injury of the nonpenetrat-
ing type, the term closed head-injury may be assigned [5]. The simplification made to these 
terms adds an element of simplicity for when medical professionals present cases to patient’s 
families and loved ones.
2.2. Anatomical description of the brain, relevant to penetrating traumatic brain injuries
To aid in our understanding of traumatic brain injuries and later on the rise of intracranial 
pressure, it is imperative we touch upon the anatomy of the human brain such that successive 
sections of this chapter can be understood with a greater degree of clarity. The human brain, 
the core of the central nervous system, controls a vast majority of bodily processes and func-
tions. The center of knowledge and core processing is perhaps the most important  regulator 
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of human life, yet only weighs between three to five pounds. The first line of defense for 
the brain is called the cranium, often referred to as the skull, and this shields the brain with 
a tough bone structure [6]. The brain covering itself contains three layers: the dura, arach-
noid and pia. Interestingly enough, there also exists a space between the pia and arachnoid 
referred to as the subarachnoid complex. This area houses a vast network of veins, arteries, 
and nerves, which channels both blood and electrochemical potential to the heart and back to 
the brain. This subarachnoid complex is prone to trauma as well as constriction or full block-
age. Any trauma that may cause constriction or blockage will also pose a greater threat to the 
tissue of the brain. Thus far, we have discussed the cranium and the brain that it encloses; 
however, the brain does not fill the entire volume of the cranium, and the volume remaining 
is filled by cerebrospinal fluid (CSF), serving as a nutrient-rich cushion around the brain, and 
blood-vessels. It is important to note that the volume of the cranium is fixed, and the brain 
fills a fixed volume of the cranium and the cerebrospinal fluid (CSF); therefore, any trauma 
that may alter the volume of the cranial region can be devastating, a concept referred to as 
increased intracranial pressure (ICP), which we will discuss in immense detail throughout 
this chapter [7].
A common misconception we wish to clear up is the designation of the upper and lower brain, 
and it is often misunderstood that the brain is a term used only for the upper brain, the ovular 
shaped region; however, the lower brain that houses vital components such as the brainstem is 
also indeed part of the human brain. At the lowest point of the brain (brainstem), there exists a 
small circular opening for which the skull and the spinal cord merge to form the complete cen-
tral nervous system. As we mentioned above, the brainstem in fact is one of the most important 
parts of the lower brain as it houses a plethora of intricate nerve fibers, which pass information 
from the brain to the spinal cord and to the body as a whole. Another crucial component of 
the lower brain is the cerebellum, a small mass of neuronal tissue that is responsible for the 
regulation and coordination of motor skills and balance. Without this region of the brain, the 
miracle of the human touch, whether it be the detailed touch of an artist or the intricate lifesav-
ing work done at the microscopic level by a neurosurgeon, will not be possible. The ovular 
region of the human brain, known as the upper brain, is a large mass of neuronal tissue divided 
into white and gray matter. Gray matter houses neuronal cell bodies, axons, and dendrites, 
while white matter is entirely made up of axons, which connect other gray matter components 
together [8]. The upper brain is composed of the cerebral cortex, which is the largest component 
of the human brain, and this region is divided into two hemispheres: left and right. Uniquely 
enough, the right side of the brain will control left side of the body and vice versa. Despite the 
left and right hemisphere designations of the cerebral cortex, there are also various other desig-
nations called regional designations, and these include the frontal lobes, temporal lobe, parietal 
lobe, and occipital lobe. The frontal lobes are comprised of the left and right lobes, which are 
located directly behind the forehead, and these control one’s intellectual abilities, decision mak-
ing, behavior, and emotions. The temporal lobe is behind the ear and extends to the center of 
the head; from a bird’s eye view of the brain, it is directly behind the frontal lobe and extends 
outward from both ears. This lobe controls speech, understanding, memory, and information 
retention [9]. Our ability to read, write, and understand spatial relationships is due to the efforts 
made by the parietal lobe, which is located at the rear of the head, specifically the upper section 
of the convex ovular protrusion site. Also at the rear of the head, but significantly lower, is the 
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occipital lobe, which controls sight. While we have covered the brain as a whole, it is important 
to note that throughout the cerebral cortex there are also several sites that are denoted by spe-
cific names, which we will discuss when the pathology becomes relevant to those particular 
areas, and these sites are rich in nerves and also house nerve centers. These are called diencepha-
lons; a more notable diencephalon is the hypothalamus, which regulates homeostasis of the 
body. These include control over body temperature, hunger, thirst, and arousal. Why discuss 
the anatomy of the brain to this extent? We hope that since we have discussed anatomy to this 
extent, the discussion of traumatic brain injury to regions of the brain can be better understood. 
Damage to any area of the brain can result in both impairment to the functions they regulate and 
permanent damage to the physical anatomy leading to cognitive deficiencies as well [10, 11].
2.3. Classifying traumatic brain injuries using GSC
The immediate identification of traumatic brain injuries is crucial for the positive-outlook prog-
nosis of a patient, and injuries of this nature present in a spectrum of severities each consisting 
of unique clinical presentations. To simplify the spectra of severity, a classification system has 
been established that rates injuries in three categories: mild, moderate, and severe. This clas-
sification system is called the Glasgow Coma Scale (GSC), a system readily utilized for the clas-
sification of thousands of traumatic brain injury cases per year [12]. The Glasgow Coma Scale is 
used in evaluating a patient’s level of consciousness based on a sum of several categories rang-
ing between 3 and 15. Evaluation of patient consciousness is based upon his or her responsive-
ness to general verbal, visual, and motor stimuli [13]. The numerical score of this assessment 
will classify the severity of a patient’s brain injury; a score closer to 15 demonstrates near-full 
neurological ability and consciousness, while a score closer to 3 demonstrates a case in which 
severe brain injury has occurred and the patient is in a deep coma. A Glasgow Coma Scale score 
of 13–15 indicates a mild brain injury, while a score of 9–12 indicates a moderate brain injury, 
and any patient scoring 8 or below is said to have incurred a severe brain injury [12, 14]. Table 1 
demonstrates the rating categories medical staff use to generate a Glasgow Coma Scale score.
To generate the Glasgow Coma Scale (GSC) score, a score will be determined for each cat-
egory, followed by the summation of all three categories to generate a score between 3 and 15.
2.4. Introduction to intracranial pressure
An accumulation of pressure above the normal standard within the skull is denoted as elevated 
intracranial pressure (ICP), a severe condition that requires immediate remediation. While the 
1 2 3 4 5 6
Visual Eyes closed Eyes open to 
sharp stimuli
Eyes open to 
sounds








Muscle flexion and 
bodily movement
Able to localize 
touch
Appears to have 
normal movement








Table 1. The Glasgow Coma Scale (GSC) rating score sheet.
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initial cause for the onset of ICP may vary greatly from patient to patient, the anatomical factors 
that play a role in intracranial pressure are simply the cranium, the brain, and the cerebrospinal 
fluid that fills the volume in between the cranium and the brain. Within medicine, the standard 
unit to measure pressure is “mm Hg,” which stands for millimeters of mercury, the distance 
mercury travels in a closed system to indicate pressure. For a normal adult, at rest, and in 
good health, the intracranial pressure should remain between 6 and 16 mm Hg [15]. A unique 
high-order organismal advantage humans possess is the ability to maintain homeostasis, much 
like many functions of the body, and homeostasis is crucial to the long-term survival of the 
human. Within the brain, there are also many hemostatic mechanisms in place to maintain a 
healthy and acceptable pressure within the cranium. The management of intracranial pressure 
is in fact done through the regulation of the metabolism and production of cerebrospinal fluid 
(CSF). Since CSF is the only liquid occupying the volume between the cranium and brain, there 
is no other regulation factor that the body can maintain. The size of the brain and skull only 
grows slightly after birth and cannot be altered freely to reduce pressure; thus, the regulation 
of CSF metabolism and production are crucial in maintaining a healthy and acceptable intra-
cranial pressure [16]. In the event that intracranial pressure rises to the limits of the normal 
and healthy range, immediate remediation is necessary. When the ICP reaches 17–18 mmHg, 
concern should be raised, and when ICP ranges between 19 and 25 mmHg, immediate relief of 
pressure is required to prevent damage to regions of the brain [17].
2.5. Monro-Kellie hypothesis
The Monro-Kellie hypothesis was proposed by Doctors Alexander Monro and George Kellie in 
correspondence to the impact cerebrospinal fluid (CSF) has on the pressure-volume relationship 
within the cranium. This particular hypothesis describes the intracranial volume-pressure rela-
tionship, which we briefly mentioned above. According to the Monro-Kellie hypothesis, the fixed 
volume of the cranium is comprised of the brain, cerebrospinal fluid, blood, and the pressure of 
blood flowing to the brain called cerebral perfusion pressure (CPP). Within the fixed volume, 
the cranium and all components within come to form a state of equilibrium, which we discussed 
as homeostasis. This hypothesis states that an increase in volume of any one of the cranial con-
stituents results in an increase of pressure within the cranium unless there is an equal or greater 
reduction of volume in another cranial constituent [18]. Buffers within the cranium respond to 
increases in cranial constituent volume in hopes to reduce pressure to avoid brain damage. In the 
event that cranial pressure rises, typically due to an increase in lesion volume, a decrease in blood 
and cerebrospinal fluid is observed in hopes to reduce intracranial pressure [19].
2.6. Rise of intracranial pressure resulting from brain injury
The most common cause of increased intracranial pressure, also known as intracranial hyper-
tension, is traumatic brain injuries. The neurological complication that is accompanied by 
a traumatic brain injury is the loss of pathophysiologic regulators of the brain that results in 
deregulation of intracranial pressure management [20]. The volume of an average adult’s skull is 
approximately 1500 mL, in which over 85% is occupied by the brain, 10% by arterial blood, and 
5% by cerebrospinal fluid [21]. Cerebral profusion pressure (CPP), which we briefly mentioned 
above as the pressure created by cerebral blood flow, is dependent on two factors: both mean sys-
temic arterial pressure (MAP) and ICP. Mean systemic arterial  pressure (MAP) and intracranial 
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pressure (ICP) are related to cerebral perfusion pressure (CPP) based on the relationship that: 
CPP = MAP – ICP. Mean systematic arterial pressure (MAP) is calculated by the summation of 
one-third systolic blood pressure (SBP) and two-thirds diastolic blood pressure (DBP), in abbrevi-
ated form as: MAP = 1/3 SBP + 2/3DBP [22]. In line with the Monro-Kellie hypothesis, an increase 
in intracranial pressure (ICP) is remediated physiologically by a decrease in cerebral perfusion 
pressure (CPP) [23]. Through the relationship we described above, a decrease in CPP dictates that 
there is a decrease in blood pressure and therefore autoregulation of intracranial pressure. While 
a decrease in CPP regulates ICP, it is also vital that a minimum CPP be maintained such that the 
brain can receive adequate amounts of blood. Normal CPP ranges between 50 and 165 mmHg, 
and in the event that CPP drops below 50 mmHg, the brain will not receive adequate amounts 
of blood, thus creating further complications with maintaining normal cerebral blood flow [24]. 
When the brain is subjected to injury, the physiological homeostatic functions of the brain may 
be deregulated or not functional at all. A normal pathology will maintain the normal CPP of 
50–165 mmHg while regulating an appropriate ICP level as well. In the event that the intracranial 
pressure (ICP) rises past 16 mmHg, blood vessels within the brain will constrict to reduce the 
blood to flow to cranium thus lowering the intracranial pressure. Thus, when a traumatic brain 
injury occurs, to the extend where the brain’s homeostatic functions are lost, intracranial pressure 
(ICP) increases and physiological regulatory functions are nonoperable [25].
2.7. Negative outlook of untreated increased intracranial pressure
The management of an increased intracranial pressure is vital for the successful outcome of the 
patient. In the event that an elevated intracranial pressure goes untreated, two major complica-
tions arise. The first is the temporary or permanent loss of vision (depending on severity) and the 
second is development of a severe headache that lasts for more than 48 hours [26]. Additionally, 
patients will also begin to exhibit irritability, lethargy, slow cognitive processes, as well as abnor-
mal behavior. Untreated elevated intracranial pressure may subject the patient to enter a state of 
near-unconsciousness, coma, or even death [27]. Another concern for patients presenting with ele-
vated intracranial pressure is the possibility for damage incurred through brain herniation. Brain 
herniation is a deadly condition that arises when the ICP is extremely high, and this condition 
presses the brain tissue against the hard cranium causing compression damage to the brain. This 
extreme pressure may also cause the brain to shift across vital structures that connect the brain to 
the spinal cord, such as the falx cerebri [28]. While brain herniation may also occur in the absence 
of an elevated ICP, it is more frequently seen in patients that do in fact present with a severely 
elevated ICP. High pressure within the cranium induces brain herniation and that can constrict or 
block arterial blood flow to various parts of the brain, proving to be fatal. In Figure 1, the CT scan 
of a patient presenting with left-side brain herniation of the parahippocampal gyrus, a structure of 
the brain that is paramount in memory encoding and memory retrieval, is shown, and damage to 
this area may result in memory disturbances and schizophrenia [29].
2.8. Clinical presentation of patients with ICP resulting from TBI
Patients presenting with elevated intracranial pressure (ICP) resulting from traumatic brain 
injury (TBI) exhibit symptoms very much similar to patients presenting solely with elevated 
ICP due to other factors. Traumatic brain injury patients, depending on severity, will present 
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with a series of symptoms that are generally along the lines of unconsciousness/coma, head-
ache, vomiting, nausea, compromised motor function, blurred vision, headache, perception 
of noise that is not present (ringing sounds), as well as difficulty keeping balance. The one 
symptom we did not mentioned above that we will discuss in depth now is elevated intracra-
nial pressure resulting from traumatic brain injury. Alongside all the symptoms a TBI patient 
will exhibit, ICP will also cause several symptoms to be present much similar to those already 
seen in TBI patients [30]. Typical elevated ICP patients present clinically with headache, vom-
iting, nausea, reduced state of consciousness, and vision blurriness. Figure 3 demonstrates the 
overlap of the symptoms a TBI patient will exhibit versus symptoms an elevated ICP patient 
will exhibit. But do note that a common symptom of a TBI patient is in fact also elevated 
ICP, but elevated ICP in not only brought on my a TBI, and other factors may contribute to 
elevated ICP such as hydrocephalus and intracranial hemorrhage [33].
Now that we understand the clinical features of traumatic brain injury (TBI) patients as well 
as elevated intracranial pressure (ICP) patients, let us combine the two as one pathology, 
elevated intracranial pressure due to a traumatic brain injury. Referring back to Table 2, we 
know how similar the presenting symptoms may be; thus, let us briefly discuss how a diag-
nosis may be made. First and foremost, if the history of the patient prior to clinical presenta-
tion involves any form of trauma to the head, a TBI can be easily diagnosed. The next step 
will be to conduct a neurological evaluation, often using the Glasgow Coma Scale (GCS). 
A symptom of a TBI may be elevated intracranial pressure (ICP), which can be diagnosed 
primarily through a neurological exam conducted by a neurologist or neurological surgeon. 
Additionally, radiological imaging via computed topography (CT) scan and magnetic reso-
nance imaging (MRI) can be utilized to determine the presence of the cause as well as the 
severity of the elevated intracranial pressure [34].
Figure 1. CT scan demonstrating brain herniation on left side due to temporal lobe hemorrhage [29].
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2.9. Radiology of intracranial pressure caused by TBI
Radiographic imaging to determine the presence of a traumatic brain injury that results in 
the onset of elevated intracranial pressure is crucial for the high-certainty diagnosis medical 
professionals seek to provide. Radiographic methods utilized in the diagnostic process are 
CT scans and MRI, and over the years, a series of common trends have been documented in 
regard to radiological findings, which we will discuss in this section. In Table 3, we highlight 
the core radiological findings that we will discuss in this section.
The second cranial nerve, also known as the optic nerve, transmits visual information from the 
retina through a complex nervous network to the brain. This cranial nerve develops from optic 
stalks during early embryonic development and is supported by nonneuronal glial cells [35]. 
In patients presenting with elevated intracranial pressure, the optic nerve region of the CT and 
MRI scan shows a clear area of prominence. Within this region, approximately 40% of elevated 
ICP patients present with optic nerve tortuosity, a condition in which optic nerve is twisted 
or alerted slightly from physiologically normal conditions [36, 37]. In approximately 45% of 
patients, the subarachnoid space surrounding the optic nerve is highly prominent and pro-
trudes the space of the optic nerve [38]. This region is comprised of delicate connective tissue as 
well as channels that contain cerebrospinal fluid (CSF), and this region plays a role is creating 
channels for intercommunication between the arachnoid, the pia mater, and the CSF. The optic 
disk, also referred to as the optic nerve head, is the terminal point for ganglion cells leaving 
the eye. The region is a physiologically normal blind spot each eye possesses due to the lack of 




Reduced motor function—balance Present Present
Vision deficits—blurriness Present Present
Ringing of ear Present Not Present
Elevated intracranial pressure (ICP) Present ←Symptom of TBI
Table 2. Comparison of TBI and ICP symptoms.
Regions of common trends in radiological findings
Optic nerves




Subdermal adipose tissue accumulation
Table 3. CT and MRI radiological findings for ICP resultant of TBI.
Traumatic Brain Injury - Pathobiology, Advanced Diagnostics and Acute Management184
photoreceptors, rods, and cones in that region [39]. A condition involving the swelling of optic 
disk is called papilledema, and in patients that present with elevated ICP, this is a common 
occurrence [40]. Due to the fact that the optic disk is continuous with the subarachnoid space, 
swelling of this region contributes greatly to elevated intracranial pressure. This swelling can 
manifest itself into two forms: either as an intraocular protrusion of the optic nerve or as seen in 
a vast majority of papilledema patients, a flattening of the posterior white of the eye, sclera [41]. 
In Figure 2, the nodular enhancement of the optic nerves is seen, from a case study on irregular 
papilloedema [42]. The last pathology we will discuss in relevance to the optic nerve is the MRI 
enhancement of the intraocular optic nerve, which is anterior to the sclera’s lamina cribrosa. 
This pathology is seen in approximately 50% of elevated ICP due to TBI and adds to the intra-
cranial pressure via degeneration of optic nerves, causing damage to axonal components lead-
ing to increased ICP and irreversible blindness in a vast majority of glaucoma patients [43].
Another pathology consistent with the increase in intracranial pressure is bilateral venous 
sinus stenosis, which may be prevalent in segments of the transverse sinus. Stenosis involves 
the constriction of a venous tract, in this case of the sinus [44].
Pseudotumor cerebri (PTC) is a clinically relevant pathology that presents with increased 
intracranial pressure, but the etiology is not entirely understood. This syndrome tends to 
target women over men, and specifically obese women. PTC, as mentioned above, results 
from increased ICP and presents clinically with headaches, nausea, as well as changes in 
vision. Through radiographic efforts, this pathology is linked with elevated CSF, a connec-
tion that was dismissed in the earlier years of medicine. Interestingly enough, patients with 
elevated ICP who also present with PTC have the following pathologies: an empty sella, an 
enhancement of the optic nerve head, and a tortuosity of the optic nerve [45]. An empty sella, 
otherwise known as empty sella syndrome (ESS), is where the pituitary gland is physically 
altered, and thus the sella turcica becomes filled with CSF [46]; see Figure 3. ESS is usually 
highly indicative of an increased intracranial pressure.
Thus far, we have discussed three of the most common radiological findings, in a nonspecific 
order. The next pathology we will discuss is the enlargement of the arachnoid resulting from 
an increase of ICP due to TBI. ESS, or empty sella syndrome, we just discussed also plays 
Figure 2. Papilledema, enhancement of optic nerve leading to increased ICP [42].
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a major role in the enlargement of the arachnoid. Actually, approximately 70% of enlarged 
arachnoid cases due to increased ICP are because of empty sella syndrome, replacing the 
void volume of the pituitary gland with CSF [47, 48]. Some cases of arachnoid enlargement 
are attributable to an enlarged Meckel cave [49]. The Meckel cave, previously known as the 
trigeminal cave, is a CSF-filled arachnoid pouch, which protrudes from the posterior cranial 
fossa, the most posterior segment of the cranium base where the cerebellum and brainstem 
reside. In the event of a TBI, cerebrospinal fluid (CSF) fills into this cavity, expanding the 
volume of this cavity, resulting in an increase of intracranial pressure due to the narrow and 
space-limited anatomy of this brain region [50, 51].
The next pathology that we will discuss that is commonly observed in radiological investiga-
tions of increased ICP in TBI patients is tonsillar ectopia, synonymous to cerebellar tonsils, a 
disorder of the papa-axial mesoderm. In this pathology, the cerebellar tonsils elongate due to 
pressure, leading the cerebellum to be pushed through the foramen magnum of the cranium 
resulting in additional increased intracranial pressure as well as tonsillar herniation [52]. This 
condition is life threatening, as cranial pressure is heavily diverted onto the medulla oblon-
gata, a vital sector of the brain that controls cardiac and respiratory functions [53, 55].
As we have now discussed the most common radiological presentation for patients present-
ing with increased intracranial pressure due to a traumatic brain injury, we will begin our 
discussion on the treatment pathways to remediate these issues. Management and treatment 
for increased intracranial pressure can utilize both a nonsurgical and surgical intervention, 
and in the sections to follow, we will discuss both management options.
2.10. Nonsurgical care of increased intracranial pressure
Nonsurgical management of increased intracranial pressure can take on a multitude of forms. 
In this section, we will discuss the many medicinal options available to patients presenting with 
increased intracranial pressure resulting from a traumatic brain injury. The quickest and least 
Figure 3. Sagittal T2-weighted image of ESS in an elevated ICP patient [31, 32]. (Left) Pathological findings of “empty 
sella syndrome” where the arrow points at a completely empty sella. (Right) Anatomically and pathologically healthy 
individual, for comparison.
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invasive method to reduce a patient’s ICP to a normal range is by elevating the patients head to 
30° with respect to the horizontal plane [56]. The elevation of a patient’s head does not directly 
act toward lowering the ICP; in fact, an elevated head aims to reduce CPP, which in turn reduces 
ICP by increasing venous drainage (based on the relationship we discussed in an earlier section 
of this chapter) [57]. A common practice typically conducted by first responders to patients that 
show clear signs of a traumatic brain injury and increased intracranial pressure in the field is to 
medically induce a state of minimal hyperventilation. In 1970, hyperventilation of a patient with 
an increased ICP was a common practice and used readily, and it was not until a study came out 
stating the adverse outcomes of a prolonged state of hyperventilation; in fact, it was shown to 
have caused cerebral ischemia, a condition where an insufficient amount of blood is delivered 
to the brain. Today, hyperventilation is still used in the treatment of an increased ICP but only 
to a pCO2 level of 25 mmHg. Immediate initial treatment may call for the hyperventilation of a 
patient to pCO2 levels of 30–40 mmHg but for no greater than 2–5 min, before returning back to 25 mmHg. More often than not, hyperventilation is not necessary for the treatment of an 
increased ICP, and there are better methods that were developed compared to the hyperventila-
tion that was introduced in the 1970s [58, 59]. An organic biological medication, mannitol, which 
is a sugar alcohol typically administered intravenously is used to decrease high blood pressure 
in the eyes as well as to decrease intracranial pressure [60]. With effects seen 10–20 min after 
administration and lasting up to 8–10 h, mannitol is metabolized by the liver and excreted mostly 
by the kidney. Mannitol has a biological half-life of 100 min and is mostly a synthetic drug, with 
only a 7% bioavailability [61]. The biochemical mechanism by which mannitol acts on human 
physiology is bimodal, meaning the drug can mechanistically act in two ways. The first pathway 
is to lower osmotic diuresis through the reduction of swelling within the cerebral parenchyma. 
The second pathway is to lower the viscosity of the blood, therefore allowing for more lami-
nar blood flow through veins and arteries eventually causing a state of vasoconstriction, which 
decreases the intracranial volume of blood and thus a lowered intracranial pressure [62, 63]. 
The mechanistic bimodal action by mannitol makes the drug a popular choice among patients 
presenting with an increased ICP due to TBI [64]. A class of drugs known as barbiturates has 
been widely debated in its effects on lowering intracranial pressure, while this class of drugs can 
successfully complete the task at hand, the use of barbiturates often causes a state of decreased 
myocardial function and decreased CPP, which can cause higher rates of morbidity and mor-
tality if left unmonitored. Thus, we do not advocate the use of barbiturates as a drug for the 
treatment of elevated ICP, unless as a last resort option. For your understanding, a barbiturate is 
a synthetic chemical drug that acts as a depressant of the central nervous system capable of pro-
ducing a wide spectrum of effects [65]. While barbiturates are not a recommended class of drugs 
to utilize in the treatment of elevated ICP due to TBI, it in fact can and has been utilized as a last 
resort option for a procedure called “barbiturate-induced coma,” which aims to immediately 
reduce intracranial pressure in patients that are unresponsive to any other form of nonsurgical 
medical treatment. The barbiturate of choice for this procedure is pentobarbital, which requires 
electroencephalogram (EEG) monitor during intravenous use. While using this drug, it is of key 
importance to monitor the blood pressure of the patient such that the patient does not slip into a 
hypotensive state. Hypotension resulting from the use of a barbiturate dramatically increases the 
rate of mortality two-fold, from 25 to 50% mortality [66]. In addition to the intravenous medica-
tion administered to patients presenting with increased ICP due to TBI, the administration of a 
Management of Intracranial Pressure in Traumatic Brain Injury
http://dx.doi.org/10.5772/intechopen.72829
187
hypertonic solution to maintain a state of euvolemia, a condition in which bodily liquid volume, 
viscosity, and circulation are all normal, is also imperative. These hypertonic solutions depend 
on the results of a complete blood diagnostic panel and differ from patient to patient, and the 
most common intravenous hypertonic solution administered is a 0.8–8% NaCl solution [67]. In 
patients where intravenous euvolemia cannot be established and maintained, remediation of 
coagulopathy must be placed as a medical team’s highest priority [68]. Coagulopathy is a state 
in which the blood’s ability to coagulate is diminished or impaired, resulting in a variable vis-
cosity of the blood and therefore further complications in the treatment of elevated intracranial 
pressure. Normal human physiology tightly regulates the viscosity of blood and its coagulating 
ability, and in patients that have suffered a traumatic brain injury, the release of biochemical 
pathway intermediate, thromboplastin, causes abnormal blood clotting. These abnormal clotting 
factors can be fatal if not remediated quickly; therefore, blood transfusions for these patients is 
the quickest and most preferred method in correcting blood coagulating abilities and eliminating 
coagulopathy. Patients on anticoagulating mediations due to high cholesterol, such as heparin 
or warfarin, who sustain a traumatic brain injury that results in elevated intracranial pressure 
are typically at risk and thus require immediate blood transfusion [69]. Approximately 1 in 10 
TBI patients that present with elevated ICP also demonstrates a fever 24–48 hours after the initial 
injury, and this elevation in temperature is in fact part of the body’s inflammatory response [70]. 
Often in patients where the hypothalamus has been damaged, elevated body temperature is 
noticed due to an underlying infection of the region. While the biochemical mechanism of this 
observation is not understood, what is understood is that immediate elimination of the infec-
tion is required for a successful recovery. This unexplained fever is often called “neurological 
fever,” and unlike a fever caused by a cold or viral infection, neurological fever tremendously 
increases metabolic demand [71]. In patients with GCS scores less than or equal to 8 with imag-
ing that demonstrates signs of cerebral edema, placement of external ventricular drain in a sterile 
fashion is recommended to allow CSF drainage. This procedure can be completed at bedside or 
in the operating room with the overall goal of decreasing cerebral edema by CSF drainage. In 
cases where intracranial pressure remains at or above 22 mmHg, despite all strategies discussed 
above, surgical intervention will need to be considered. In this section, we have discussed the 
nonsurgical and medicinal approach in resolving an elevated intracranial pressure; however, 
in any remedy for the management of ICP, it is important to remember that the overall goal is 
to reduce and prevent any agitation of the intracranial region. In the section to follow, we will 
discuss the surgical option for the management of intracranial pressure in the event that nonsur-
gical interventions do not remediate the issue.
2.11. Surgical care of increased intracranial pressure
Immediate and rapid surgical care of patients presenting with elevated intracranial pressure 
due to a traumatic brain injury is vital for the positive prognosis of the patient, especially if non-
surgical routes did not suffice in the remediation of intracranial pressure. Intracranial lesions 
resulting in an increased ICP typically present in patients as a state of reduced consciousness, 
and this pathology requires a surgical procedure called “rapid decompression.” This surgery 
is self-explanatory at the elementary level, as the surgical efforts aim to reduce intracranial 
pressure (“decompress”) and do so as soon as possible. Prior to operation, a complete patient 
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profile must be reobtained, meaning that radiological evidence alone is not enough to proceed 
with decompression surgery; a neurological examination coupled with radiological evidence 
that is convincing without any doubt is what surgical staff must aim to achieve. Similar to 
many forms of surgery, patient age plays a major role. For decompression surgeries, patients 
that are young (12 years old or younger) or elder (70 years old or older) pose a greater risk to 
surgical harm, and this harm is referred to as intracranial hemorrhage, excessive bleeding from 
tissue and venous tract within the intracranial region [72]. The first form of decompression sur-
gery that we will discuss is decompressive craniotomy, a procedure in which a segment of the 
cranium is removed to relieve intracranial pressure and to create additional room for the brain 
swelling. This decompressive surgery evolved from a primitive form of surgery called trephin-
ing. Today, this surgical practice is a last resort option and has been more successful in younger 
patients rather than in older patients, another surgical option is craniotomy for evacuation of 
focal hemorrhage which can be subdural, epidural or intraparenchymal in nature [73]. The next 
surgical practice we will discuss that is used in the treatment of elevated intracranial pressure 
due to a TBI, which causes an over production of CSF, is a ventriculoperitoneal (VP) shunt. 
A VP shunt is a medical device that relieves pressure from the brain due to fluid accumula-
tion, and this shunt drains the excess fluid and allows it to be metabolized and reabsorbed. 
Normally, CSF will coat the brain and spinal cord and be reabsorbed into the blood, and in a 
disrupted flow, the CSF can build up and create pressure on the brain causing damage. A com-
mon source for deregulation for CSF production and reabsorption is traumatic brain injury, 
and in these cases, it is common for CSF to cause damage to the brain [74]. Prior to surgery, a 
patient will be instructed to halt any consumption of food and water by mouth (PO) at least 
8–12 h before surgery. Then a surgical nurse will prepare the area behind the ear for surgical 
incision. The shunt is a catheter, a thin flexible but heavy-duty tube that is used to drain excess 
liquid. A neurological surgeon will then make a small incision behind the ear and using a 
burr-drill will create a small hole within the patient’s scalp [75]. With the hole in the cranium, 
surgical staff will insert one catheter into the brain and another subdermal catheter will be 
placed behind the ear. A thin tube will travel down the patient’s torso and into the abdominal 
cavity. The excess CSF will drain into the abdominal cavity relieving intracranial pressure [76]. 
In patients that present with intracranial pressure regularly, a pump may be placed to activate 
this channel when ICP rises. For the context in which we have been discussing, this shunt will 
be used to relieve patients of increased ICP following a TBI.
2.12. Medication utilization
Management of elevated intracranial pressure due to a traumatic brain injury requires the utili-
zation of many forms of medication. Thus far, we have discussed a few drugs that directly target 
elevated intracranial pressure, but often these pathologies require surgical intervention. For that 
to occur, a wide variety of drugs must be utilized to stabilize the patient from common complica-
tions that arise. In this section, we will touch upon the class of drugs utilized prior to neurologi-
cal surgery. The most prevalent presurgical complication presenting in medical centers today is 
intracranial hemorrhages; see Figure 4. Intracranial hemorrhages denote bleeding of the brain; 
medical personnel often utilize prophylactic anticonvulsants, and the term prophylactic refers 
to the act of committing an action before hand and the term anticonvulsants refers to a set of 
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pharmacological drugs that block sodium channels or enhance GABA (gamma- aminobutyric 
acid) function [78, 79]. Physiologically, these drugs can save a life in the event of a seizure as 
well as reduce bleeding in the brain prior to surgery [80]. There are many drugs that can be used 
that are considered in this pharmacological class, and the first of its kind was discovered in 1882 
(paraldehyde); today, the drug of choice is phenytoin or fosphenytoin [81]. In adults, a loading 
dose of phenytoin or fosphenytoin is administered, typically in adults 18 mg anticonvulsant per 
kilogram (kg) of patient body weight. Then, therapeutic levels of 20 milligram (mg) per decili-
ter (dL) are maintained until intracranial hemorrhage subsides [82]. Prolonged use of anticon-
vulsant drugs may result in gingival hyperplasia, an enlargement of one’s gingiva (commonly 
known as gums) as well as randomized hair growth in men and unwanted male-hair growth in 
women, known as hirsutism [83–85]. In the unfortunate case where a pediatric patient is sub-
jected to elevated intracranial pressure due to a traumatic brain injury that is accompanied by 
intracranial hemorrhage, the drug of choice changes to phenobarbital, where a 20 mg/1 kg body 
weight loading dose is given, followed by a therapeutic dose of 10–50 mg/dL.
2.13. Patient follow-up and future care
Many patients that present to medical centers for treatment of mild to severe traumatic brain 
injury and are subjected to an elevated intracranial pressure will tremendously benefit from 
numerous outpatient care options. As traumatic brain injury patients typically have difficulty 
with daily tasks, physical and occupation therapy is highly recommended as patients try to 
regain a normal lifestyle. Additionally, times following a traumatic incident can be hard emo-
tionally and spiritually, and thus it is also beneficial for patients to receive counseling care 
from professional as well as from family and loved ones. The initial efforts to reestablish the 
life the patient once had is difficult and both mentally and physically taxing, and support and 
counseling are of key essence.
Figure 4. CT scan of subdural in a TBI patient presenting for surgical intervention [77]. Presentation of severe intracranial 
pressure buildup resulting from TBI. Images depict transverse CT images from ventral (left) to dorsal views (right), 
respectively, 5 h after injury with a Glasgow Coma Scale (GSC) score of 3 (an extremely severe form). This imaging depicts 
right focal subdural hematoma.
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3. Conclusion
Throughout this chapter, we have discussed the many applications and forms of medical 
care pertaining to the presence of elevated intracranial pressure resulting from traumatic 
brain injury. Throughout this chapter, we hope that you have learned the key diagnostic 
characteristics, medical treatment, and future outcomes for patients experiencing this trau-
matic pathology. While we hope no patient has to suffer from TBI, we wish all medical staff 
best of luck in their efforts to remediate these conditions and for continual excellence in 
patient care.
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